Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus ; volume:14 ; number:1 ; day:4 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.11.2024), 1-11, 12.2024
- Creator
-
Czarnota, Anna
Raszplewicz, Aleksandra
Sławińska, Aleksandra
Bieńkowska-Szewczyk, Krystyna
Grzyb, Katarzyna
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-78049-3
- URN
-
urn:nbn:de:101:1-2501222104054.710859974152
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Czarnota, Anna
- Raszplewicz, Aleksandra
- Sławińska, Aleksandra
- Bieńkowska-Szewczyk, Krystyna
- Grzyb, Katarzyna
- SpringerLink (Online service)
Other Objects (12)
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Rabies-based vaccine induces potent immune responses against Nipah virus
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Rabies-based vaccine induces potent immune responses against Nipah virus
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Rabies-based vaccine induces potent immune responses against Nipah virus
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses
A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models